SCHEMBL17028070

SCHEMBL17028070

FC(F)(F)c1ccnc(CC2CCCC2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLS O94925 5/20 0.43
NOS3 P29474 1/20 0.43
NOS2 P35228 1/20 0.43
HCRTR1 O43613 1/20 0.43
HCRTR2 O43614 1/20 0.43
MAPK1 P28482 1/20 0.41
SLC6A4 P31645 2/20 0.40
HTR2C P28335 1/20 0.40
HTR2B P41595 1/20 0.40
TACR1 P25103 1/20 0.39
KCNH2 Q12809 1/20 0.39
SYK P43405 1/20 0.38
ADRB1 P08588 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
USP30 Q70CQ3 1/20 0.36
TRPV3 Q8NET8 2/20 0.36
MBOAT4 Q96T53 1/20 0.36
CSNK1D P48730 1/20 0.36
OPRM1 P35372 1/20 0.35
OPRK1 P41145 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25145644 0.86 MAPK1 (0.55) NOS3NOS2HCRTR1HCRTR2MAPK1
SCHEMBL16544505 0.83 CYP1A2 (0.38) GLS
SCHEMBL20281970 0.81 MAPK1 (0.52) NOS3NOS2MAPK1SLC6A4HTR2C
SCHEMBL25857336 0.81 CYP1A2 (0.35) GLSHCRTR1HCRTR2
SCHEMBL19822067 0.80 MEN1 (0.35) GLSMAPK1
SCHEMBL17007252 0.78 HCRTR1 (0.48) GLSNOS3NOS2HCRTR1HCRTR2
SCHEMBL17007104 0.78 HCRTR1 (0.51) GLSNOS3NOS2HCRTR1HCRTR2
SCHEMBL17007237 0.77 HCRTR1 (0.41) GLSNOS3NOS2HCRTR1HCRTR2
SCHEMBL27246501 0.77 SLC6A4 (0.41) GLSNOS3NOS2HCRTR1HCRTR2
SCHEMBL17028048 0.75 TRPA1 (0.44) HCRTR1SYKTRPV3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3107898-B1 1,2-SUBSTITUTED CYCLOPENTANES AS OREXIN RECEPTOR ANTAGONISTS TAKEDA PHARMACEUTICALS CO (JP) 2021-01-06 EP disclosed
EP-3107898-A1 1,2-SUBSTITUTED CYCLOPENTANES AS OREXIN RECEPTOR ANTAGONISTS Takeda Pharmaceutical Company Limited (JP) 2016-12-28 EP disclosed
WO-2015124932-A1 1,2-SUBSTITUTED CYCLOPENTANES AS OREXIN RECEPTOR ANTAGONISTS TAKEDA CAMBRIDGE LIMITED (GB) 2015-08-27 WO disclosed